FDA's Drug Risk Promo Proposal Slammed By All Sides
The U.S. Food and Drug Administration has sparked intense criticism with new guidance describing circumstances in which drugmakers can tell doctors that medications are safer than once thought, with Big Pharma...To view the full article, register now.
Already a subscriber? Click here to view full article